GLP-1 drugs, or glucagon-like peptide-1 substances, are representing as a remarkable breakthrough in managing hyperglycemia. These modern therapies work by stimulating insulin secretion and lowering glucagon output , often leading to improved glycemic control and possible weight reduction . Furthermore , research suggest they might present heart-re